Krystal Biotech KRYS
NASDAQ KRYS
$308.81 +2.31 (+0.75%)
At close: Nov 11, 2026 · 4:00 PM EST

Krystal Biotech (KRYS) Consolidated Net Income (2016 - 2026)

Updated

Krystal Biotech (KRYS) reported Consolidated Net Income of $63.05 million for Q3 2026, down 20.6% from $79.37 million a year earlier but up 15.1% from the prior quarter.

Analysis

Krystal Biotech (KRYS) Consolidated Net Income (2016 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Krystal Biotech's Consolidated Net Income came in at $225.14 million, up 13.2% year-over-year; for FY2025, it was $204.83 million, up 129.7% from FY2024.

  • By year, Consolidated Net Income came in at $89.16 million in FY2024 (+715.6%), $10.93 million in FY2023, -$139.98 million in FY2022 and -$69.57 million in FY2021.
  • Five-year quarterly Consolidated Net Income spans a low of -$50.22 million in Q1 2022 and a high of $80.75 million in Q3 2023.
  • Year over year, Consolidated Net Income gained in six of the last seven quarters, with growth averaging 122.0%.
  • The high point for year-over-year Consolidated Net Income in five years was Q4 2024 (growth of 423.6%); the low point was Q3 2024 (a decline of 66.4%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $54.77 million (Q2 2026), $55.93 million (Q1 2026) and $51.39 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 210.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.12 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.25 Bn
10 Krystal Biotech 9.08 Bn 5.67 Bn 119.79 Mn 58.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 58.17 Mn
Jun 30, 2026 52.06 Mn
Mar 31, 2026 53.17 Mn
Dec 31, 2025 51.44 Mn
Sep 30, 2025 79.31 Mn
Jun 30, 2025 39.10 Mn
Mar 31, 2025 36.31 Mn
Dec 31, 2024 43.78 Mn
Sep 30, 2024 29.33 Mn
Jun 30, 2024 15.23 Mn
Mar 31, 2024 -5,000.00
Dec 31, 2023 9.71 Mn
Sep 30, 2023 80.60 Mn
Jun 30, 2023 -33.29 Mn
Mar 31, 2023 -44.72 Mn
Dec 31, 2022 -31.31 Mn
Sep 30, 2022 -29.78 Mn
Jun 30, 2022 -28.46 Mn
Mar 31, 2022 -51.00 Mn
Dec 31, 2021 -21.96 Mn
API Access

Krystal Biotech Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=KRYS&period=max&api_key=YOUR_API_KEY